SUTENT 25 mg/1

SUTENT 25 mg capsules contain sunitinib malate, a medication used to treat certain types of cancer. This oral medication is designed to target specific proteins involved in cancer cell growth.

SUTENT 25 mg capsules are primarily used in the treatment of advanced kidney cancer and certain types of gastrointestinal stromal tumors (GIST). Sunitinib malate works by inhibiting the growth of cancer cells. Patients should consult their healthcare provider to determine if this medication is suitable for their condition.

Common effects of SUTENT 25 mg capsules may include fatigue, nausea, and diarrhea. Some users may also experience skin discoloration or changes in hair color. These effects vary among individuals and are not exhaustive.

SUTENT 25 mg capsules should be handled with care and stored as directed. It is important to follow the advice of a healthcare professional regarding the use of this medication. Patients should be aware of potential side effects and report any severe reactions to their doctor.

SUTENT 25 mg capsules may interact with certain medications, including those metabolized by the liver's cytochrome P450 system. It is advisable to inform your healthcare provider about all medications you are taking to avoid potential interactions.